Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Carl

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Urology|December 24, 1997
A placebo controlled study of mycophenolate mofetil used in combination with cyclosporine and corticosteroids for the prevention of acute rejection in renal allograft recipients: 1-year results. The European Mycophenolate Mofetil Cooperative Study GroupM Wiesel, S Carl
Digestive Diseases (Basel, Switzerland)|April 6, 2002
Pathology and pathogenesis of hepatocellular carcinomaC Röcken, S Carl-McGrath
Zentralblatt Fur Chirurgie|January 1, 1978
[Deadly brain injuries (author's transl)]J Schöche, E Rauchfuss, S Carl
Der Urologe. Ausg. A|July 1, 1998
[Mycophenolate mofetil (MMF) for prevention of kidney transplant rejection. A new immunosuppressive agent. International Mycophenolate Mofetil Study Group]S Carl, M Wiesel, G Staehler
Virology|January 14, 1998
A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potentialM Elbel, S Carl, S Spaderna, et al.
Urologie (Heidelberg, Germany)|May 31, 2023
[Long-term evaluation of low-dose-rate (LDR) brachytherapy in localized prostate cancer]N Carl, J Rassweiler, J Andreas, et al.
Histology and Histopathology|September 16, 2006
Ectopeptidases in tumour biology: a reviewS Carl-McGrath, U Lendeckel, M Ebert, et al.
Journal of Clinical Pathology|September 29, 2005
Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinomaC Röcken, J Licht, A Roessner, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 1, 1991
Alterations in human lung parenchyma after cytostatic therapyK Kayser, H J Gabius, S Carl, et al.
The Journal of Biological Chemistry|September 3, 1998
Secretory interleukin-1 receptor antagonist gene expression requires both a PU.1 and a novel composite NF-kappaB/PU.1/ GA-binding protein binding siteM F Smith, V S Carl, T Lodie, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Urology|December 24, 1997
A placebo controlled study of mycophenolate mofetil used in combination with cyclosporine and corticosteroids for the prevention of acute rejection in renal allograft recipients: 1-year results. The European Mycophenolate Mofetil Cooperative Study GroupM Wiesel, S Carl
Digestive Diseases (Basel, Switzerland)|April 6, 2002
Pathology and pathogenesis of hepatocellular carcinomaC Röcken, S Carl-McGrath
Zentralblatt Fur Chirurgie|January 1, 1978
[Deadly brain injuries (author's transl)]J Schöche, E Rauchfuss, S Carl
Der Urologe. Ausg. A|July 1, 1998
[Mycophenolate mofetil (MMF) for prevention of kidney transplant rejection. A new immunosuppressive agent. International Mycophenolate Mofetil Study Group]S Carl, M Wiesel, G Staehler
Virology|January 14, 1998
A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potentialM Elbel, S Carl, S Spaderna, et al.
Urologie (Heidelberg, Germany)|May 31, 2023
[Long-term evaluation of low-dose-rate (LDR) brachytherapy in localized prostate cancer]N Carl, J Rassweiler, J Andreas, et al.
Histology and Histopathology|September 16, 2006
Ectopeptidases in tumour biology: a reviewS Carl-McGrath, U Lendeckel, M Ebert, et al.
Journal of Clinical Pathology|September 29, 2005
Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinomaC Röcken, J Licht, A Roessner, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 1, 1991
Alterations in human lung parenchyma after cytostatic therapyK Kayser, H J Gabius, S Carl, et al.
The Journal of Biological Chemistry|September 3, 1998
Secretory interleukin-1 receptor antagonist gene expression requires both a PU.1 and a novel composite NF-kappaB/PU.1/ GA-binding protein binding siteM F Smith, V S Carl, T Lodie, et al.
Pageof 8